Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 485

1.

Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function.

Curran HV, Verheyden SL.

Psychopharmacology (Berl). 2003 Aug;169(1):91-103. Epub 2003 May 21.

PMID:
12759801
2.

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.

Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.

J Psychopharmacol. 2006 Mar;20(2):211-25. Review.

PMID:
16510479
3.

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

Morgan MJ, McFie L, Fleetwood H, Robinson JA.

Psychopharmacology (Berl). 2002 Jan;159(3):294-303. Epub 2001 Oct 12.

PMID:
11862362
4.
5.

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

Parrott AC, Lasky J.

Psychopharmacology (Berl). 1998 Oct;139(3):261-8.

PMID:
9784083
6.

Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users.

Dafters RI, Hoshi R, Talbot AC.

Psychopharmacology (Berl). 2004 May;173(3-4):405-10. Epub 2003 Aug 30.

PMID:
12955295
7.

Memory deficits associated with recreational use of "ecstasy" (MDMA).

Morgan MJ.

Psychopharmacology (Berl). 1999 Jan;141(1):30-6.

PMID:
9952062
8.

Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study.

de Sola S, Tarancón T, Peña-Casanova J, Espadaler JM, Langohr K, Poudevida S, Farré M, Verdejo-García A, de la Torre R.

Psychopharmacology (Berl). 2008 Oct;200(3):425-37. doi: 10.1007/s00213-008-1217-5. Epub 2008 Jun 26.

PMID:
18581098
9.

Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy").

Quednow BB, Kühn KU, Hoppe C, Westheide J, Maier W, Daum I, Wagner M.

Psychopharmacology (Berl). 2007 Jan;189(4):517-30. Epub 2006 Jan 20.

PMID:
16425060
10.

Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.

Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O.

J Psychopharmacol. 2006 May;20(3):389-99.

PMID:
16574713
11.

Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.

de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.

J Psychopharmacol. 2008 Jul;22(5):498-510. doi: 10.1177/0269881107081545. Epub 2008 Jan 21.

PMID:
18208910
12.

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study.

McCann UD, Mertl M, Eligulashvili V, Ricaurte GA.

Psychopharmacology (Berl). 1999 Apr;143(4):417-25.

PMID:
10367560
13.

Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.

Fox HC, McLean A, Turner JJ, Parrott AC, Rogers R, Sahakian BJ.

Psychopharmacology (Berl). 2002 Jul;162(2):203-14. Epub 2002 May 9.

PMID:
12110998
14.

Angry cognitive bias, trait aggression and impulsivity in substance users.

Bond AJ, Verheyden SL, Wingrove J, Curran HV.

Psychopharmacology (Berl). 2004 Jan;171(3):331-9. Epub 2003 Sep 10.

PMID:
13680074
15.

Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.

Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M.

J Psychopharmacol. 2006 May;20(3):373-84.

PMID:
16574711
16.
17.

Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects.

Jacobsen LK, Mencl WE, Pugh KR, Skudlarski P, Krystal JH.

Psychopharmacology (Berl). 2004 May;173(3-4):383-90. Epub 2003 Nov 28.

PMID:
14647960
18.

Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users.

Curran HV, Rees H, Hoare T, Hoshi R, Bond A.

Psychopharmacology (Berl). 2004 May;173(3-4):425-33. Epub 2004 Jan 20.

PMID:
14735288
19.

Chronic MDMA (ecstasy) use, cognition and mood.

McCardle K, Luebbers S, Carter JD, Croft RJ, Stough C.

Psychopharmacology (Berl). 2004 May;173(3-4):434-9. Epub 2004 Apr 16.

PMID:
15088077
20.

Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence.

Dafters RI, Duffy F, O'Donnell PJ, Bouquet C.

Psychopharmacology (Berl). 1999 Jul;145(1):82-90.

PMID:
10445376

Supplemental Content

Support Center